Kepos Capital LP Danaher Corp Transaction History

Kepos Capital LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$235.51 - $267.98 $15,779 - $17,954	-67 Reduced 16.58%	337 $84,000
Q1 2024 May 10, 2024	SELL	$224.58 - $256.19 $9,207 - $10,503	-41 Reduced 9.21%	404 $101,000
Q4 2023 Feb 12, 2024	BUY	$185.1 - $233.13 $185 - $233	1 Added 0.23%	445 $103,000
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $5,127 - $5,842	22 Added 5.21%	444 $98,000
Q2 2023 Aug 10, 2023	BUY	$224.99 - $256.14 $49,272 - $56,094	219 Added 107.88%	422 $101,000
Q4 2022 Feb 13, 2023	SELL	$241.42 - $282.29 $4,828 - $5,645	-20 Reduced 8.97%	203 $54,000
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $9,882 - $60,296	-40 Reduced 15.21%	223 $58,000
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $111,441 - $140,840	-470 Reduced 64.12%	263 $67,000
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $54,026 - $66,309	-210 Reduced 22.27%	733 $215,000
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $275,431 - $310,256	943 New	943 $310,000

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.